The Patent Finder

Virco N.V.

Also on record
Records under this name other than patents Virco N.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Virco N.V.

PatentTitleStatus Expires Confidence
US 8,563,236Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
Term ended
Term ended Oct 9, 2021 · From the USPTO record
Term endedTerm ended Oct 9, 2021From the USPTO record
US 7,235,387Method for mutation detection in HIV-1 using pol sequencing
Term ended
Term ended May 16, 2021 · From the USPTO record
Term endedTerm ended May 16, 2021From the USPTO record
US 6,800,463Method for mutation detection in HIV-1 using pol sequencing
Term ended
Term ended Aug 18, 2020 · From the USPTO record
Term endedTerm ended Aug 18, 2020From the USPTO record
US 7,494,768Mutational profiles in HIV-1 protease and reverse transcriptase correlated with phenotypic drug resistance
Term ended
Term ended May 30, 2020 · From the USPTO record
Term endedTerm ended May 30, 2020From the USPTO record
US 6,221,578Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains
Formerly held
Term ended
Term ended Jul 24, 2018 · From the USPTO record
Term endedTerm ended Jul 24, 2018From the USPTO record
US 7,058,616Method and system for predicting resistance of a disease to a therapeutic agent using a neural network
Formerly held
Lapsed on the fee record
Ended Jun 6, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jun 6, 2018From the USPTO record
US 8,574,831Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistance
Lapsed on the fee record
Ended Nov 5, 2017 · From the USPTO record
Lapsed on the fee recordEnded Nov 5, 2017From the USPTO record
US 7,292,944Establishment of biological cut-off values for predicting resistance to therapy
Formerly held
Lapsed on the fee record
Ended Nov 6, 2015 · From the USPTO record
Lapsed on the fee recordEnded Nov 6, 2015From the USPTO record
US 7,206,699Methods for measuring therapy resistance
Formerly held
Lapsed on the fee record
Ended Apr 17, 2015 · From the USPTO record
Lapsed on the fee recordEnded Apr 17, 2015From the USPTO record
US 6,528,251Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strains
Formerly held
Lapsed on the fee record
Ended Mar 4, 2015 · From the USPTO record
Lapsed on the fee recordEnded Mar 4, 2015From the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited